Leading Cancer Center No Longer Offering Zantac to Patients

(Bloomberg) -- One of the nation’s leading cancer centers will no longer offer Zantac and its generics to patients, as it reviews the potential cancer risk from the discovery of a carcinogen in the...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.